This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Nadrich & Cohen LLP
Testimony in the ongoing Johnson & Johnson metal hip trial has allegedly uncovered evidence that the manufacturer inadequately tested for potential dangers in its hip products, according to a New York Times article. Los Angeles personal injury attorney Jeff Nadrich responds.
Los Angeles, CA (PRWEB) February 13, 2013
New testimony from the ongoing DePuy ASR hip lawsuit* against Johnson & Johnson reveals that J&J may have severely underestimated the potential for failure in its Articular Surface Replacement, or A.S.R. implant, according to a new article from the New York Times. As the article outlines, a J&J internal review—conducted after the 2010 recall of the ASR—found that the company’s orthopedic unit “had used inadequate or incorrect standards in trying to assess some of those risks before first selling the implant in 2003.”
The report was introduced last week in Los Angeles Superior Court, in the first DePuy lawsuit to go to trial. More than 10,000 similar lawsuits have also been filed in the United States, all of them stemming from side effects and complications related to the ASR and other DePuy hip devices. The Times further points out that one of the company’s compliance managers—Jimmy Smith—was asked about the report, and confessed that company officials had not used appropriate engineering controls to try to anticipate the A.S.R’s potential problems. “They did their job, but they could have done it better,” Mr. Smith said.
The Times article further outlines that in a separate testimony, DePuy engineer Graham Isaac testified that before selling the A.S.R., the company only tested its performance on laboratory equipment at one angle of implantation. Orthopedic surgeons, however, can implant the artificial hip from a variety of angles.
Jeff Nadrich, a Los Angeles personal injury attorney and defective device lawyer, has been providing commentary about this case on his DePuy hip blog, and recently weighed in about these new revelations. According to Nadrich, “This trial has answered a lot of questions about how Johnson & Johnson was able to secure FDA approval for such a dangerous device, but it should also serve as an important lesson about the need for greater review and accountability for new drugs and devices.”
Nadrich further encourages other DePuy side effect victims to come forward and seek legal representation. “Johnson & Johnson has admitted that the company should have done more to foresee these problems, and patients should not be forced to suffer severe physical and financial consequences as a result.”
About Nadrich & Cohen: Jeffrey Nadrich is a personal injury attorney with Nadrich & Cohen, a California based law firm with offices in 18 locations across California. The firm has offices in Arcadia, Bakersfield, Fresno, Irvine, Long Beach, Modesto, Oakland, Oxnard, Palm Springs, Redding, Riverside, Sacramento, San Bernardino, San Diego, San Francisco, San Jose, Santa Rosa, and Tracy. Nadrich & Cohen handles all types of wrongful death and serious injury accident cases, including auto, truck, bus, motorcycle, and bicycle accidents, pedestrian collisions, boating accidents, dog bites, defective product cases and nursing home abuse. Victims are encouraged to call 1-800-718-4658 for a free consultation with a Nadrich & Cohen attorney.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebdepuy-hip/att/prweb10406376.htm